The Degradation Chemistry of Prasugrel Hydrochloride: Part 1-Drug Substance

被引:7
|
作者
Baertschi, Steven W. [1 ]
Maxwell-Backer, Lindsay [1 ]
Clemens, Matthew [1 ]
Smitka, Tim A. [1 ]
Draper, Jerry R. [1 ]
Taylor, K. Wayne [1 ]
Kaerner, Andreas [1 ]
Jansen, Patrick J. [1 ]
机构
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
stability; degradation; forced degradation; stress testing; structure elucidation; prasugrel; effient; degradation products; impurities; LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; PREDICTION; IMPURITIES; BEHAVIOR; HPLC; IDENTIFICATION; AUTOXIDATION; OXIDATION;
D O I
10.1016/j.xphs.2019.04.008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Prasugrel hydrochloride is the active ingredient in Effient (TM), a thienopyridine platelet inhibitor. An extensive study of the degradation chemistry of prasugrel hydrochloride (LY640315 hydrochloride) has been carried out on the drug substance (part I) and on the drug product (part II, future article) using a multidimensional approach including hydrolytic, oxidative, and photolytic stressing, computational chemistry, HPLC analysis, and structure elucidation by various spectroscopic techniques. The major degradation products formed from the drug substance under the various stress conditions have been isolated and structures unambiguously determined, and the pathways leading to these products have been proposed. Fourteen new (not previously disclosed) products were discovered and characterized, in addition to 4 degradation products that had been previously identified in the literature. The pathways indicate that prasugrel is susceptible to hydrolysis, autoxidation (both radical-initiated and single-electron mediated), and peroxide-mediated oxidation; in solution, prasugrel is susceptible to photodegradation. (c) 2019 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:2842 / 2857
页数:16
相关论文
共 50 条
  • [21] Impurity Profile Study of Venlafaxine Hydrochloride, an Antipsychotic Drug Substance
    Saravanan, Mohanarangam
    Kumar, Karra Suresh
    Reddy, Padi Pratap
    Satyanarayana, Bollikonda
    SYNTHETIC COMMUNICATIONS, 2010, 40 (13) : 1880 - 1886
  • [22] Computational chemistry and computer-aided drug discovery: part 1
    Bajorath, Juergen
    FUTURE MEDICINAL CHEMISTRY, 2016, 8 (14)
  • [23] Gender in the Substance of Chemistry, Part 2: An Agenda for Theory
    Kovacs, Agnes
    HYLE, 2012, 18 (02): : 121 - 143
  • [24] Study of the forced degradation behavior of prasugrel hydrochloride by liquid chromatography with mass spectrometry and liquid chromatography with NMR detection and prediction of the toxicity of the characterized degradation products
    Singh, Dilip Kumar
    Sahu, Archana
    Handa, Tarun
    Narayanam, Mallikarjun
    Singh, Saranjit
    JOURNAL OF SEPARATION SCIENCE, 2015, 38 (17) : 2995 - 3005
  • [25] Identification of oxidative degradation impurities of Olanzapine drug substance as well as drug product
    Rao, P. Sreenivasa
    Ray, Uttam Kumar
    Hiriyanna, S. G.
    Rao, Sumathi V.
    Sharma, Hemant Kumar
    Handa, Vijay Kumar
    Mukkanti, K.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2011, 56 (02) : 413 - 418
  • [26] Chemistry in India Part 1
    Maienfisch, Peter
    Mehta, Goverdhan
    CHIMIA, 2012, 66 (12) : 889 - 889
  • [27] Thermal degradation, Part 1
    Coating System Design, Inc.
    J Prot Coat Linings, 9 (09):
  • [28] Polyglycolide: Degradation and drug release. Part II: Drug release
    Susan Hurrell
    Ruth E. Cameron
    Journal of Materials Science: Materials in Medicine, 2001, 12 : 817 - 820
  • [29] Polyglycolide: Degradation and drug release. Part II: Drug release
    Hurrell, S
    Cameron, RE
    JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2001, 12 (09) : 817 - 820
  • [30] Degradation Pathway of a Taxane Derivative DS80100717 Drug Substance and Drug Product
    Tamura, Kousuke
    Ono, Makoto
    Kawabe, Takefumi
    Ohara, Motomu
    Yonemochi, Etsuo
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2020, 68 (04) : 392 - 397